Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder.
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.
Reviewing the Unmet Needs of Patients with Multiple Sclerosis.
A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
Epidemiology of Neuromyelitis Optica in the United States: A Multicenter AnalysisEpidemiology of NMO.
A genome-wide association study of brain lesion distribution in multiple sclerosis.
FDA Accepts Filing of BETACONNECT™* for Relapsing-Remitting Multiple Sclerosis Patients Taking BETASERON® (interferon beta-1b)
Guillain-Barré syndrome-like-onset neurosarcoidosis positive for immunoglobulin G anti-N-acetylgalactosaminyl-GD1a antibody.
Fatigue, depression and sleep disturbances in Iranian patients with multiple sclerosis.
Glatiramer acetate during early pregnancy: A prospective cohort study.
Receptos announces issuance of composition of matter patents covering proprietary lead product candidate RPC1063
The Stigma Scale for Chronic Illnesses 8-Item Version (SSCI-8): Development, Validation and Use Across Neurological Conditions.
US court permits generic version of Teva MS drug a year sooner
Gender identity disorders and multiple sclerosis risk: A national record-linkage study.
Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions.
Assessment of statistical significance and clinical relevance.
Discontinuation of Disease-Modifying Treatment for Multiple Sclerosis
IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis.
Mitoxantrone for multiple sclerosis.
Good Early Results for HERV Suppressor in MS
Human herpesvirus 6 and effectiveness of interferon β1b in multiple sclerosis patients.
Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab Treatment.
[Intractable vomiting as first manifestation of neuromyelitis Optica.]
Estimating Time to Disease Progression Comparing Transition Models and Survival Methods-An Analysis of Multiple Sclerosis Data.
Regional Susceptibility to TNF-α Induction of Murine Brain Inflammation via Classical IKK/NF-κB Signalling.

Pages